Pharmaniaga Berhad (7081.KL)
- Previous Close
0.3350 - Open
0.3350 - Bid 0.3350 x --
- Ask 0.3400 x --
- Day's Range
0.3350 - 0.3400 - 52 Week Range
0.3000 - 0.5100 - Volume
635,300 - Avg. Volume
1,139,791 - Market Cap (intraday)
490.018M - Beta (5Y Monthly) 1.34
- PE Ratio (TTM)
-- - EPS (TTM)
-0.5100 - Earnings Date May 16, 2024 - May 20, 2024
- Forward Dividend & Yield 0.07 (20.29%)
- Ex-Dividend Date Dec 8, 2022
- 1y Target Est
0.31
Pharmaniaga Berhad, an investment holding company, operates as an integrated pharmaceutical company in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; supply, trading, and installation of medical and hospital equipment; and trading and wholesaling of consumer products. The company also manufactures and sells generic drugs; over-the-counter medicines; conducts research and development of pharmaceutical products; and manufactures, distributes, trades in, and sells food supplements. In addition, it distributes and trades in diagnostic products; and operates community pharmacies under the RoyalePharma brand name. The company was founded in 1994 and is based in Shah Alam, Malaysia. Pharmaniaga Berhad is a subsidiary of Boustead Holdings Berhad.
www.pharmaniaga.comRelated News
Performance Overview: 7081.KL
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 7081.KL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 7081.KL
Valuation Measures
Market Cap
490.02M
Enterprise Value
1.60B
Trailing P/E
--
Forward P/E
10.96
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.13
Price/Book (mrq)
--
Enterprise Value/Revenue
0.46
Enterprise Value/EBITDA
-2.71
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.28%
Return on Assets (ttm)
-0.17%
Return on Equity (ttm)
--
Revenue (ttm)
3.4B
Net Income Avi to Common (ttm)
-77.45M
Diluted EPS (ttm)
-0.5100
Balance Sheet and Cash Flow
Total Cash (mrq)
127.44M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
178.61M
Research Analysis: 7081.KL
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 7081.KL
7081.KL does not have Company Insights